4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-22-028455
Chief Financial Officer bought 85,404 shares at an average $0.38 ($32,501)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hunt Jonathan Robert Chief Financial Officer | 2022-12-01 | Purchase | +53,204 | $0.38 | $20,265 | 159,510 | D |
| Hunt Jonathan Robert Chief Financial Officer | 2022-12-05 | Purchase | +32,200 | $0.38 | $12,236 | 191,710 | D |
| Open-market purchases · 85,404 sh · avg $0.38 · $32,501 | |||||||
Loading xslF345X03/rdgdoc.xml…